Study of how new blood vessels affect skin diseases
Part of Skin clinical trials.
This study looks at how new blood vessel growth may be involved in skin conditions. It may help researchers learn whether blocking this process could become a future treatment, and you may contribute by having a skin biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 16 years old or older
- Be willing to have a skin biopsy (a small sample taken from the skin)
- Be able to follow study instructions and directions
- If you are under 16, you cannot join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a skin biopsy to look at “gene signals” (transcriptomics) in patients with active vasculitis that shows up on the skin. It may help researchers understand what is happening in your disease and how different types of vasculitis differ.
This study looks at how atopic dermatitis (eczema), psoriasis, or other autoimmune skin diseases change over time and how the body responds to anti-inflammatory signals. Your information and—if eligible—samples help researchers find patterns that could guide better treatments.
This study collects and stores biological samples (biospecimens) from people with skin conditions, people at risk, or healthy volunteers. It helps researchers better understand dermatologic diseases and support future skin research.
This study collects skin samples and medical information from people with skin conditions caused by their immune system. It helps researchers better understand these diseases and develop new treatments.
This trial collects a small skin sample (like a biopsy) from people with congenital heart disease. The samples help prepare for future clinical trials that may test new heart treatments.
This study looks at skin lymphomas (a type of white blood cell cancer that starts in the skin) to find factors that predict how the disease will progress and to identify new ways to treat it. By joining, you help researchers understand and improve treatment for this condition.
Hear when a new Dermatologic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.